Showing results (61-70 of 630) with videos related to
Sort By:
Pageof 63
Acta Chirurgica Scandinavica|June 1, 1990
Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacementT Mätzsch, D Bergqvist, H Fredin, et al.Upsala Journal of Medical Sciences|January 1, 1989
Coagulation and fibrinolysis during the normal menstrual cycleA Siegbahn, V Odlind, U Hedner, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIXS He, M Blombäck, G Jacobsson Ekman, et al.Thrombosis and Haemostasis|October 1, 1991
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasmaO Nordfang, S Valentin, T C Beck, et al.Transfusion|September 1, 1983
Shelf-life of bank blood and stored plasma with special reference to coagulation factorsL Nilsson, U Hedner, I M Nilsson, et al.Blood|May 1, 1983
A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodiesB Theodorsson, U Hedner, I M Nilsson, et al.Acta Medica Scandinavica|January 1, 1979
Comparison of streptokinase with heparin: late results in the treatment of deep venous thrombosisL Johansson, G Nylander, U Hedner, et al.Pharmacology & Toxicology|September 1, 1993
Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factorM K Thomsen, P Wildgoose, P Nilsson, et al.Acta Medica Scandinavica|March 1, 1975
Intrauterine death and circulating anticoagulant ("antithromboplastin")I M Nilsson, B Astedt, U Hedner, et al.Acta Radiologica: Diagnosis|January 1, 1984
Tolerance and biochemical effects from intravenous injection of ioxaglate in healthy volunteersP E Nilsson, P Aspelin, U Nyman, et al.Pageof 63